Understanding inflammation and ferritin levels in critically ill patients
Part of Hormones & metabolism, Infections clinical trials.
This trial looks at two conditions in people who are critically ill (in intensive care): hyperinflammation (when the body's infection-fighting system overreacts) and hyperferritinemia (when a protein called ferritin is too high in the blood). It aims to understand these conditions better and may help improve care for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently or were critically ill, meaning you required intensive care.
- Your hospital admission happened between January 2020 and December 2024.
- There are no other restrictions—this trial is open to all critically ill patients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a blood test called “glycosylated ferritin” to help doctors better identify certain dangerous inflammatory conditions. It may help clarify whether your high iron-related marker is due to inflammation rather than other causes.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This trial looks at specific cell damage processes (called ferroptosis and pyroptosis) in very sick ICU patients. The goal is to learn more about these processes so doctors can better treat life-threatening organ failure caused by conditions like sepsis, trauma, or severe bleeding.
This study looks at how the body's genes respond in liver failure and sepsis to better understand these conditions and potentially improve treatment.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.